Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company's newly FDA-approved oral GLP-1, Foundayo (orforglipron) through its Medoffering and affiliated medical groups.